SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001360865-14-000061
Filing Date
2014-12-16
Accepted
2014-12-15 19:41:23
Documents
6
Period of Report
2014-08-31

Document Format Files

Seq Description Document Type Size
1 PETLIFE PHARMACEUTICALS, INC. ANNUAL REPORT ON FORM 10-K FOR THE YEAR ENDED AUGU ptlf10k2014.htm 10-K 376910
2 EXHIBIT 3.2 exhibit32.htm EX-3 49041
3 EXHIBIT 31.1 exhibit311.htm EX-31 5313
4 EXHIBIT 31.2 exhibit312.htm EX-31 5328
5 EXHIBIT 32.1 exhibit321.htm EX-32 2409
6 EXHIBIT 32.2 exhibit322.htm EX-32 2430
  Complete submission text file 0001360865-14-000061.txt   442731
Mailing Address 433 N. CAMDEN DR. BEVERLY HILLS CA 90210
Business Address 433 N. CAMDEN DR. BEVERLY HILLS CA 90210 (310) 279-5152
PetLife Pharmaceuticals, Inc. (Filer) CIK: 0001354591 (see all company filings)

IRS No.: 331133537 | State of Incorp.: NV | Fiscal Year End: 0831
Type: 10-K | Act: 34 | File No.: 000-52445 | Film No.: 141288078
SIC: 2860 Industrial Organic Chemicals